Related Experiment Videos
Effects of terguride in patients with Huntington's disease
F Stocchi1, A Carta, A Berardelli
1Department of Neuroscience, La Sapienza University, Rome, Italy.
Clinical Neuropharmacology
|October 1, 1989
Abstract:
trans-Dihydrolisuride, a partial dopamine receptor agonist, was tested for its effects on chorea in a double-blind, crossover clinical study in 10 patients with Huntington's disease. In eight patients, a neurophysiological evaluation was also performed. No reduction in choreic movements or improvement in voluntary movement performance was observed. However, in some patients, there was a slight improvement in patients' alertness and a reduction of the movement reaction time.